comparemela.com

Latest Breaking News On - Caleb liptak - Page 1 : comparemela.com

DEEP BLUE INVESTMENT ADVISORS EXPANDS TEAM WITH FOUR NEW HIRES

Artistry Restaurants Names New CEO, Partner | RestaurantNewsRelease com

Artistry Restaurants Names New CEO, Partner | RestaurantNews com

DEEP BLUE INVESTMENT ADVISORS ANNOUNCES NEW DIRECTOR OF CLIENT SERVICES

etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users

etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users News provided by Share this article Share this article GAINESVILLE, Fla. & BOSTON, May 4, 2021 /PRNewswire/ Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV. The study, dubbed MyTPill, will assess patient adherence using two electronic adherence tracking technologies: the ID-Cap ™ System from etectRx and an electronic pill box. The study will provide insight on how digital pill systems can help patients who have significant health risks due to nonadherence. The MyTPill Study, which marks etectRx s third NIH-sponsored study at Brigham and Women s Hospital within the last two years, kicked off in March, and will include 80 patients over the next four years. Patients will track their use of HIV medication by using the ID-Cap System for three month

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.